Saladax Biomedical names Harter president and CEO

Monday, June 18, 2012 11:35 AM

Saladax Biomedical, a Bethlehem, Penn.-based privately held company developing and commercializing novel diagnostic, has appointed Kevin M. Harter as president and chief executive officer.

Harter, a co-founder and senior vice president of the Life Science Greenhouse, a public-private life sciences investment partnership, has been serving as interim CEO of Saladax since January 2012. From 2007 to 2011, Harter served as executive chairman of Saladax, a LSG-portfolio company, where he led multiple, successful funding rounds and strategic deals for the company.

He also co-founded Keystone Medical Systems in 1990 and managed the company through significant growth until its acquisition by publicly-held Continental Medical Systems. Prior to Keystone, Harter held several positions within the Pennsylvania Blue Shield organization, including vice president, technology, and has contributed significantly to the development of the field of electronic claims, electronic medical records and physician practice management.  He has held more than two dozen board seats in healthcare, technology and financial companies. 

Share:          
CWWeekly

February 23

Venture capital investors funding novel drug R&D three times more than companies repurposing, improving existing drugs

In appreciation: Karen Woodin will be remembered for her teaching, writing and lasting friendships

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs